{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T13:33:13Z","timestamp":1710941593114},"reference-count":48,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.3892\/ol.2016.4584","type":"journal-article","created":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T10:51:34Z","timestamp":1463395894000},"page":"275-280","source":"Crossref","is-referenced-by-count":4,"title":["TLR7 Gln11Leu single nucleotide polymorphism and susceptibility to cutaneous melanoma"],"prefix":"10.3892","volume":"12","author":[{"given":"LISA","family":"ELEFANTI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GIORGIA","family":"SACCO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CAMILLA","family":"STAGNI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARCO","family":"RASTRELL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHIARA","family":"MENIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IRENE","family":"RUSSO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAURO","family":"ALAIBAC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,5,16]]},"reference":[{"key":"key20180108111721_b1-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","article-title":"Cutaneous melanoma","volume":"383","author":"Eggermont","year":"2014","journal-title":"Lancet"},{"key":"key20180108111721_b2-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"616170","DOI":"10.1155\/2013\/616170","article-title":"Melanoma m (zero): Diagnosis and therapy","volume":"2013","author":"Rastrelli","year":"2013","journal-title":"ISRN Dermatol"},{"key":"key20180108111721_b3-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pbiomolbio.2011.09.011","article-title":"Reviews on sun exposure and artificial light and melanoma","volume":"107","author":"Gandini","year":"2011","journal-title":"Prog Biophys Mol Biol"},{"key":"key20180108111721_b4-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jama.294.6.681","article-title":"Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years","volume":"294","author":"Christenson","year":"2005","journal-title":"JAMA"},{"key":"key20180108111721_b5-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/ijc.25411","article-title":"Trends in the incidence of nonmelanoma skin cancer in Denmark 1978\u20132007: Rapid incidence increase among young Danish women","volume":"127","author":"Birch-Johansen","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180108111721_b6-ol-0-0-4584","first-page":"273","article-title":"Melanoma m1: Diagnosis and therapy","volume":"28","author":"Rastrelli","year":"2014","journal-title":"In Vivo"},{"key":"key20180108111721_b7-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000351713","article-title":"Metastatic volume: An old oncologic concept and a new prognostic factor for stage IV melanoma patients","volume":"227","author":"Panasiti","year":"2013","journal-title":"Dermatology"},{"key":"key20180108111721_b8-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2004.10.016","article-title":"Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"key20180108111721_b9-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","article-title":"Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"key20180108111721_b10-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.ejca.2005.03.034","article-title":"Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"key20180108111721_b11-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.191999.112","article-title":"Melanoma: From mutations to medicine","volume":"26","author":"Tsao","year":"2012","journal-title":"Genes Dev"},{"key":"key20180108111721_b12-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2011.41.2452","article-title":"BRAF\/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma","volume":"30","author":"Colombino","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180108111721_b13-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molonc.2007.12.003","article-title":"Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site","volume":"1","author":"Platz","year":"2008","journal-title":"Mol Oncol"},{"key":"key20180108111721_b14-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"key20180108111721_b15-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.semcancer.2008.10.012","article-title":"Melanoma and innate immunity - Active inflammation or just erroneous attraction? Melanoma as the source of leukocyte-attracting chemokines","volume":"19","author":"Navarini-Meury","year":"2009","journal-title":"Semin Cancer Biol"},{"key":"key20180108111721_b16-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"key":"key20180108111721_b17-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"key20180108111721_b18-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fimmu.2014.00135","article-title":"Toll-like receptors and skin cancer","volume":"5","author":"Burns","year":"2014","journal-title":"Front Immunol"},{"key":"key20180108111721_b19-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-2478(02)00228-6","article-title":"Recognition of pathogen associated molecular patterns by TLR family","volume":"85","author":"Akira","year":"2003","journal-title":"Immunol Lett"},{"key":"key20180108111721_b20-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signaling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"key20180108111721_b21-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00403-012-1300-y","article-title":"Expression of TLR 3, 4, 7 and 9 in cutaneous malignant melanoma: Relationship with clinicopathological characteristics and prognosis","volume":"305","author":"Eir\u00f3","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"key20180108111721_b22-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2006.12.002","article-title":"Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors","volume":"19","author":"Miyake","year":"2007","journal-title":"Semin Immunol"},{"key":"key20180108111721_b23-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1093\/emboj\/17.21.6230","article-title":"CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation","volume":"17","author":"H\u00e4cker","year":"1998","journal-title":"EMBO J"},{"key":"key20180108111721_b24-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: Update","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology"},{"key":"key20180108111721_b25-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.it.2005.06.009","article-title":"TLR signaling and activation of IRFs: Revisiting old friends from the NF-kappaB pathway","volume":"26","author":"Moynagh","year":"2005","journal-title":"Trends Immunol"},{"key":"key20180108111721_b26-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1468-3083.2011.04049.x","article-title":"Toll-like receptors and skin","volume":"25","author":"Ermertcan","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20180108111721_b27-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1684\/ejd.2011.1526","article-title":"TLR expression in human melanoma cells","volume":"21","author":"Saint-Jean","year":"2011","journal-title":"Eur J Dermatol"},{"issue":"Suppl 1","key":"key20180108111721_b28-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12307-009-0022-y","article-title":"Cancer cells expressing toll-like receptors and the tumor microenvironment","volume":"2","author":"Sato","year":"2009","journal-title":"Cancer Microenviron"},{"key":"key20180108111721_b29-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/sj.onc.1210904","article-title":"TLR signaling by tumor and immune cells: A double-edged sword","volume":"27","author":"Huang","year":"2008","journal-title":"Oncogene"},{"key":"key20180108111721_b30-ol-0-0-4584","first-page":"20","article-title":"The expression of Toll-like receptors in dermatological diseases and the therapeutic effect of current and newer topical Toll-like receptor modulators","volume":"3","author":"Valins","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"key20180108111721_b31-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/sj.onc.1210912","article-title":"Polymorphisms in Toll-like receptor genes and risk of cancer","volume":"27","author":"El-Omar","year":"2008","journal-title":"Oncogene"},{"key":"key20180108111721_b32-ol-0-0-4584","first-page":"61","article-title":"Diagnosis of melanoma","volume":"64","author":"Maire","year":"2014","journal-title":"Rev Prat"},{"key":"key20180108111721_b33-ol-0-0-4584","first-page":"157","article-title":"TLR7 Gln11Leu single nucleotide polymorphism in patients with sarcoidosis","volume":"30","author":"Bordignon","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20180108111721_b34-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/120347541201600405","article-title":"Topical 5% imiquimod in the treatment of lentigo maligna","volume":"16","author":"Wong","year":"2012","journal-title":"J Cutan Med Surg"},{"key":"key20180108111721_b35-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180108111721_b36-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.humimm.2011.07.307","article-title":"Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk","volume":"72","author":"Kutikhin","year":"2011","journal-title":"Hum Immunol"},{"key":"key20180108111721_b37-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"e98239","DOI":"10.1371\/journal.pone.0098239","article-title":"Functional effects of Toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cells","volume":"9","author":"Tengroth","year":"2014","journal-title":"PLoS One"},{"key":"key20180108111721_b38-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7150\/ijms.8428","article-title":"The expression of Toll-like receptor 8 and its relationship with VEGF and Bcl-2 in cervical cancer","volume":"11","author":"Zhang","year":"2014","journal-title":"Int J Med Sci"},{"key":"key20180108111721_b39-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/1078-0432.CCR-12-0408","article-title":"Molecular pathways: Toll-like receptors in the tumor microenvironment - poor prognosis or new therapeutic opportunity","volume":"19","author":"Ridnour","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20180108111721_b40-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11912-004-0019-0","article-title":"Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides","volume":"6","author":"Krieg","year":"2004","journal-title":"Curr Oncol Rep"},{"key":"key20180108111721_b41-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1038\/jid.2014.194","article-title":"Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization","volume":"134","author":"Aspord","year":"2014","journal-title":"J Invest Dermatol"},{"key":"key20180108111721_b42-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1158\/1535-7163.MCT-09-1198","article-title":"Antitumor activity and immune response induction of a dual agonist of Toll-like receptors 7 and 8","volume":"9","author":"Wang","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"key20180108111721_b43-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1365-2141.2002.03645.x","article-title":"MyD88 is involved in the signaling pathway for Taxol-induced apoptosis and TNF-alpha expression in human myelomonocytic cells","volume":"118","author":"Wang","year":"2002","journal-title":"Br J Haematol"},{"key":"key20180108111721_b44-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1365-4362.2002.01597.x","article-title":"Imiquimod; an international update on therapeutic uses in dermatology","volume":"41","author":"Tyring","year":"2002","journal-title":"Int J Dermatol"},{"key":"key20180108111721_b45-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/120347540400800504","article-title":"Viral and nonviral uses of imiquimod: A review","volume":"8","author":"Gupta","year":"2004","journal-title":"J Cutan Med Surg"},{"key":"key20180108111721_b46-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1016\/j.jmb.2013.07.012","article-title":"The effects of non-synonymous single nucleotide polymorphisms (nsSNPs) on protein-protein interactions","volume":"425","author":"Yates","year":"2013","journal-title":"J Mol Biol"},{"key":"key20180108111721_b47-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"e24370","DOI":"10.1371\/journal.pone.0024370","article-title":"Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival","volume":"6","author":"Gast","year":"2011","journal-title":"PLoS One"},{"key":"key20180108111721_b48-ol-0-0-4584","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jmv.21893","article-title":"Toll-like receptor 7 rs179008\/Gln11Leu gene variants in chronic hepatitis C virus infection","volume":"82","author":"Askar","year":"2010","journal-title":"J Med Virol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4584\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T21:38:56Z","timestamp":1600551536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,16]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,16]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.3892\/ol.2016.4584"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4584","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,16]]}}}